SNDX icon

Syndax Pharmaceuticals

74 hedge funds and large institutions have $68.9M invested in Syndax Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
-1
Holders Change %
-1.33%
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
25
Reduced
22
Closed
16
Calls
$2.05M
Puts
$290K
Net Calls
+$1.76M
Net Calls Change
-$2.29M
Name Holding Trade Value Shares
Change
Shares
Change %
Point72 Asset Management
76
Point72 Asset Management
Connecticut
-$1.37M -170,000 Closed
BCM
77
Bridgeway Capital Management
Texas
-$823K -101,800 Closed
PVI
78
Pura Vida Investments
New York
-$808K -100,000 Closed
BC
79
Boxer Capital
California
-$808K -100,000 Closed
AA
80
ALPS Advisors
Colorado
-$334K -41,328 Closed
CAN
81
Claraphi Advisory Network
United States
-$129K -16,000 Closed
LPL Financial
82
LPL Financial
California
-$114K -14,130 Closed
ProShare Advisors
83
ProShare Advisors
Maryland
-$91K -11,240 Closed
BFM
84
Boothbay Fund Management
New York
-$81K -10,000 Closed
CSS
85
Cubist Systematic Strategies
Connecticut
-$17K -2,144 Closed
First Manhattan
86
First Manhattan
New York
-$12K -1,500 Closed
Royal Bank of Canada
87
Royal Bank of Canada
Ontario, Canada
-$8K -1,026 Closed
MAM
88
Meeder Asset Management
Ohio
-$2K -202 Closed
PNC Financial Services Group
89
PNC Financial Services Group
Pennsylvania
-$1K -176 Closed
Daiwa Securities Group
90
Daiwa Securities Group
Japan
-$1K -135 Closed